Bildkälla: Stockfoto

Inhalation Sciences: Rights issue outcome - Redeye

Redeye comments on ISAB’s rights issue outcome, which was subscribed to approximately 23% in total. However, as the rights issue was guaranteed up to 80%, the company receives around SEK13.7m before issue-relating costs (cSEK3.5m). As we already anticipated a capital raising, the outcome does not render any changes in our fair value range with a base case of SEK17.

Redeye comments on ISAB’s rights issue outcome, which was subscribed to approximately 23% in total. However, as the rights issue was guaranteed up to 80%, the company receives around SEK13.7m before issue-relating costs (cSEK3.5m). As we already anticipated a capital raising, the outcome does not render any changes in our fair value range with a base case of SEK17.
Börsvärldens nyhetsbrev
ANNONSER